Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma
Journal of Cellular Biochemistry · 2024-04 · 125 (4)
DOI: 10.1002/jcb.30534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, online erschienen am 15.02.2024. Verfasst von Sara A George und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Oncology, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, India, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Missense mutations in the DNA binding domain of p53 are observed frequently in esophageal squamous cell carcinoma (ESCC). Recent studies have revealed the potentially oncogenic transcriptional networks regulated by mutant p53 proteins. However, majority of these studies have focused on common “hotspot” p53 mutations while rarer mutations are poorly characterized. In this study, we report the characterization of rare, “non‐hotspot” p53 mutations from ESCC. In vitro tumorigenic assays performed following ectopic‐expression of certain “non‐hotspot” mutant p53 proteins caused enhancement of oncogenic properties in squamous carcinoma cell lines. Genome‐wide transcript profiling of ESCC tumor samples stratified for p53 status, revealed several genes exhibiting elevated transcript levels in tumors harboring mutant p53. Of these, ARF6 , C1QBP , and TRIM23 were studied further. Reverse transcription‐quantitative PCR (RT‐qPCR) performed on RNA isolated from ESCC tumors revealed significant correlation of TP53 transcript levels with those of the three target genes. Ectopic expression of wild‐type and several mutant p53 forms followed by RT‐qPCR, chromatin affinity‐purification (ChAP), and promoter‐luciferase assays indicated the exclusive recruitment of p53 mutants—P190T and P278L, to the target genes leading to the activation of expression. Several functional assays following knockdown of the target genes revealed a significant suppression of tumorigenicity in squamous carcinoma cell lines. Rescue experiments confirmed the specificity of the knockdown. The tumorigenic effects of the genes were confirmed in nude mice xenograft assays. This study has therefore identified novel oncogenic targets of “non‐hotspot” mutant p53 proteins relevant for ESCC besides validating the functional heterogeneity of the spectrum of tumor‐specific p53 mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Oncology, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India.
- Graduate Studies, Regional Centre for Biotechnology, Faridabad, Haryana, India.
- Graduate Studies, Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Apollo Hospitals, Hyderabad, Telangana, India.
- Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
ORCID-Profile: Sara A George, Murali D Bashyam
Förderung
- Indian Council of Medical Research
- Council of Scientific and Industrial Research, India
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
George, S. A., Kotapalli, V., Ramaswamy, P., Kumar, R., Gowrishankar, S., Uppin, S. G., & Bashyam, M. D. (2024). Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. Journal of Cellular Biochemistry, 125(4). https://doi.org/10.1002/jcb.30534
Vancouver
George SA, Kotapalli V, Ramaswamy P, Kumar R, Gowrishankar S, Uppin SG, et al. Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. Journal of Cellular Biochemistry. 2024;125(4). doi:10.1002/jcb.30534
BibTeX
@article{George2024,
author = {George, Sara A and Kotapalli, Viswakalyan and Ramaswamy, Pandilla and Kumar, Raju and Gowrishankar, Swarnalata and Uppin, Shantveer G and Bashyam, Murali D},
title = {Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma},
journal = {Journal of Cellular Biochemistry},
year = {2024},
volume = {125},
number = {4},
doi = {10.1002/jcb.30534}
}
EUVIMED